Depth of response may predict clinical outcome in patients with recurrent/metastatic head and neck cancer treated with pembrolizumab-containing regimensKen Saijo, Chikashi Ishioka, Hiroo Imai et al.|Frontiers in Oncology|2023Cited by 10
Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective AnalysisAkira Okita, Chikashi Ishioka, Keigo Komine et al.|The Tohoku Journal of Experimental Medicine|2018Cited by 7
Antibiotics May Interfere with Nivolumab Efficacy in Patients with Head and Neck Squamous Cell CarcinomaReio Ueta, Chikashi Ishioka, Hiroo Imai et al.|Oncology|2023Cited by 5
Comparison of Efficacy and Safety between Carboplatin-Etoposide and Cisplatin-Etoposide Combination Therapy in Patients with Advanced Neuroendocrine Carcinoma: A Retrospective StudyHiroo Imai, Chikashi Ishioka, Ken Saijo et al.|Oncology|2023Cited by 4
FOLFIRI Chemotherapy for Patients With Metastatic Urachal CarcinomaSAKURA HIRAIDE TANIGUCHI, Chikashi Ishioka, Keigo Komine et al.|Anticancer Research|2023Cited by 4